Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Debt / NOTE 0.625% 4/0
-
Market price (% of par)
-
96.67%
-
Total 13F principal
-
$385,799,649
-
Principal change
-
-$19,570,151
-
Total reported market value
-
$373,205,179
-
Number of holders
-
44
-
Value change
-
-$18,484,401
-
Number of buys
-
15
-
Number of sells
-
18
Institutional Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 as of Q1 2021
As of 31 Mar 2021,
SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 was held by
44 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$385,799,649
in principal (par value) of the bond.
The largest 10 bondholders included
Radcliffe Capital Management, L.P., CAMDEN ASSET MANAGEMENT L P /CA, Opti Capital Management, LP, DeepCurrents Investment Group LLC, JPMORGAN CHASE & CO, WOLVERINE ASSET MANAGEMENT LLC, OAKTREE CAPITAL MANAGEMENT LP, Invesco Ltd., Polar Capital Holdings Plc, and STATE STREET CORP.
This page lists
45
institutional bondholders reporting positions
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.